Inside Innovation

The Department of Defense (DOD) has partnered with Just – Evotec Biologics, a Seattle-based subsidiary of Evotec, to enhance large-scale manufacturing capabilities under the DOD’s

Principal investors at Fred Hutch Cancer Center and UW Medicine received $5.25 million in grants from the Kuni Foundation, a Vancouver, Washington-based organization dedicated to

RareCyte, a Seattle-based biotech company, recently announced that it has raised $20 million from new and current investors. This funding boost is set to significantly

Ezra, a health technology startup focused on cancer screening, opened two new locations in the Seattle area this week. Emphasizing early detection, Ezra specializes in

Seattle has been ranked as the third-best city for new college graduates according to a recent study by Zumper. The study analyzed the country’s 100

Omeros Corp., a biopharmaceutical company based in Seattle, recently named David Borges their new chief accounting officer. Borges, who joined Omeros in June 2020, has

Immunome Inc., a biotechnology company specializing in targeted cancer therapies, recently signed a lease to move into the headquarters at Bothell’s Alloy Innovation Center. Totaled

InduPro Inc., a biotechnology company dual- headquartered in Seattle and Cambridge, Massachusetts, recently announced its success in raising $85 million in Series A round funding.

Lundbeck, a biopharmaceutical company based in Bothell, Washington, recently shared its positive findings on VYEPTI, their new prescription medicine for treating migraines in adults. New

Jubilant HollisterStier, led by CEO and president Chris Preti, is undergoing a significant expansion and projects to become the No. 1 biomanufacturer in Spokane, Washington.

Cyrus Biotechnology, a Seattle-based software-enabled biotechnology startup focused on autoimmune diseases, announced it will be spinning out a new for-profit subsidiary named, Levitate Bio. The